Li Li
Founder en SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD. .
Fortuna: 686 M $ al 31/03/2024
Perfil
Li Li es un empresario que fundó Shenzhen Hepalink Pharmaceutical Group Co., Ltd. y que ha estado al frente de 5 empresas diferentes. En la actualidad, es presidente de Shenzhen Techdow Pharmaceutical Co., Ltd. y presidente de Shenzhen Hepalink Pharmaceutical Group Co., Ltd., presidente y director general de Hepalink USA, Inc. y presidente de Shenzhen Duopule Industrial Development Co., Ltd. (ambas son filiales de Shenzhen Hepalink Pharmaceutical Group Co., Ltd.). También forma parte del consejo de Cytovance Biologics, Inc. (ex presidente), Shenzhen Leren Technology Co. Ltd. y Urumqi Feilaishi Equity Investment Co. Ltd. El Sr. Li se licenció en la Universidad de Sichuan.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 30/06/2023 | 514 349 899 ( 41.24% ) | 594 M $ | 31/03/2024 | |
HIGHTIDE THERAPEUTICS INC
23.61% | 02/02/2024 | 121 515 210 ( 23.61% ) | 92 M $ | 31/03/2024 |
Cargos activos de Li Li
| Empresas | Cargo | Inicio |
|---|---|---|
| SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD. | Founder | 21/04/1998 |
Shenzhen Leren Technology Co. Ltd.
 Shenzhen Leren Technology Co. Ltd. Information Technology ServicesTechnology Services Shenzhen Leren Technology Co. Ltd. is a Chinese company that engages in technology development. | Director/Board Member | - |
| Urumqi Feilaishi Equity Investment Co. Ltd. | Director/Board Member | - |
| Shenzhen Techdow Pharmaceutical Co., Ltd. | Chairman | - |
Hepalink USA, Inc.
 Hepalink USA, Inc. Pharmaceuticals: MajorHealth Technology Hepalink USA, Inc. develops macromolecule biopharmaceutical products. The company offers scientific protein laboratories and active pharmaceutical ingredients. The company was founded in 1998 and is headquartered in Oak Brook, IL. | Chief Executive Officer | - |
Shenzhen Duopule Industrial Development Co., Ltd.
 Shenzhen Duopule Industrial Development Co., Ltd. Wholesale DistributorsDistribution Services Part of Shenzhen Hepalink Pharmaceutical Group Co., Ltd., Shenzhen Duopule Industrial Development Co., Ltd. distributes biochemical products. The private company is based in Shenzhen, China. Shenzhen Duopule Industrial Development Co. was acquired by Shenzhen Hepalink Pharmaceutical Group Co., Ltd. on May 31, 2017 for $414.58 million. | Chairman | 13/01/2014 |
Cytovance Biologics, Inc.
 Cytovance Biologics, Inc. BiotechnologyHealth Technology Cytovance Biologics, Inc. operates as a biopharmaceutical contract manufacturing company. It specializes in the production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentation. Its services include Cell Line Selection, Cell Culture, Recovery and Purification, Analytical development, Troubleshooting Existing Processes, Final Product Fill and Finish, Technology Transfer, Microbial Fermentation, Purification, Cell banking and storage, and Project management. The company was founded in 2003 and is headquartered in Oklahoma City, OK. | Director/Board Member | - |
| Shenzhen Arimab Biopharmaceuticals Co., Ltd. | Chairman | - |
Antiguos cargos conocidos de Li Li.
| Empresas | Cargo | Fin |
|---|---|---|
| HIGHTIDE THERAPEUTICS, INC. | Director/Board Member | 02/02/2024 |
Formación de Li Li.
| Sichuan University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD. | Health Technology |
| HIGHTIDE THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 7 |
|---|---|
Cytovance Biologics, Inc.
Cytovance Biologics, Inc. BiotechnologyHealth Technology Cytovance Biologics, Inc. operates as a biopharmaceutical contract manufacturing company. It specializes in the production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentation. Its services include Cell Line Selection, Cell Culture, Recovery and Purification, Analytical development, Troubleshooting Existing Processes, Final Product Fill and Finish, Technology Transfer, Microbial Fermentation, Purification, Cell banking and storage, and Project management. The company was founded in 2003 and is headquartered in Oklahoma City, OK. | Health Technology |
Shenzhen Leren Technology Co. Ltd.
Shenzhen Leren Technology Co. Ltd. Information Technology ServicesTechnology Services Shenzhen Leren Technology Co. Ltd. is a Chinese company that engages in technology development. | Technology Services |
| Urumqi Feilaishi Equity Investment Co. Ltd. | |
| Shenzhen Techdow Pharmaceutical Co., Ltd. | |
Hepalink USA, Inc.
Hepalink USA, Inc. Pharmaceuticals: MajorHealth Technology Hepalink USA, Inc. develops macromolecule biopharmaceutical products. The company offers scientific protein laboratories and active pharmaceutical ingredients. The company was founded in 1998 and is headquartered in Oak Brook, IL. | Health Technology |
Shenzhen Duopule Industrial Development Co., Ltd.
Shenzhen Duopule Industrial Development Co., Ltd. Wholesale DistributorsDistribution Services Part of Shenzhen Hepalink Pharmaceutical Group Co., Ltd., Shenzhen Duopule Industrial Development Co., Ltd. distributes biochemical products. The private company is based in Shenzhen, China. Shenzhen Duopule Industrial Development Co. was acquired by Shenzhen Hepalink Pharmaceutical Group Co., Ltd. on May 31, 2017 for $414.58 million. | Distribution Services |
| Shenzhen Arimab Biopharmaceuticals Co., Ltd. |
